Objectives To investigate the relationship between serum insulin-like growth factor-1 (IGF-1) and brachial-ankle pulse wave velocity (baPWV) in patients with essential hypertension (EH) and the influence of combined antihypertensive therapy on the serum levels of IGF-1 and baPWV, in order to illustrate the role of serum IGF-1 in the pathophysiological process of hypertensive arteriosclerosis.
Methods Thirty-four normal individuals and Sixty-eight patients with EH were enrolled. Semm IGF-1 was examined by enzyme-linked immunosorbent assay, brachial-ankle pulse wave velocity was measured by automatic arteriosclerosis detector (Omron, VP-1000). After combined antihypertensive therapy (amlodipine + Telmisartan) for 12 weeks, all EH patients needed to undertake again the tests of serum IGF-1 and baPWV, the resuts should be taken to compare with that of pre-therapy.
Results 1) Serum IGF-I levels in patients with EH were significantly higher than that in normal controls and increased with the clinical grading of EH (P < 0.05); Before the antihypertensive therapy, Serum IGF-I levels in EH patients of arteriosclerosis group were significantly higher than that of nonarteriosclerosis group (P < 0.05). 2) Before and after the antihypertensive therapy, there were not significant differences about the levels of blood-lipoids and blood-fasting sugar (P > 0.05); while the levels of serum Cr, BUN, IGF-1 and the values of baPWV showed significantly decreased after the antihypertensive therapy (P < 0.05). 3) After 12 weeks’s treatment, compared with abnormal blood pressure group, the patients in successful blood pressure control group had lower serum levels of IGF-I(P < 0.05) and smaller values of baPWV(P < 0.05). 4) Whether before or after antihypertensive therapy, serum IGF-I correlated positively with baPWV (before antihypertensive therapy rs = 0.506, P < 0.05; after antihypertensive therapy rs = 0.492, P < 0.05).
Conclusions The serum levels of IGF-1 in patients with essential hypertension are correlated with blood pressure and baPWV. IGF-I is probably involved in the pathogenesis of hypertension and promote the pathophysiological process of artery atherosclerosis in essential hypertension. After the combined antihypertensive therapy (amlodipine + Telmisartan), the degree of artery atherosclerosis improved significantly what may correlate to the decrease of serum IGF-1.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.